Rolziracetam
![]() | |
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| Synonyms | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
| CAS Number |
18356-28-0 |
| PubChem (CID) | 71893 |
| ChemSpider |
64906 |
| UNII |
RES9I0LGG5 |
| ChEMBL |
CHEMBL51396 |
| Chemical and physical data | |
| Formula | C7H9N2O2 |
| Molar mass | 139.152 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]
See also
References
- ↑ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

